Stay updated on Tezepelumab in Chronic Urticaria Clinical Trial

Sign up to get notified when there's something new on the Tezepelumab in Chronic Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tezepelumab in Chronic Urticaria Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The Locations section has been expanded to list numerous study sites across the United States (AL, CA, CO, FL, GA, IN, KS, KY, MD, MI, MO, NY, OH, RI, TN, TX), Canada (AB, NB, ON, QC), Japan (Aichi-ken, Hiroshima, Hokkaido, Kanagawa, Osaka, Tokyo), and Spain (Catalonia, Valencia). The page revision also updates to v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T09:01:04.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The page shows a new revision label: Revision: v3.3.2, replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T16:52:49.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Removed the government funding and NIH operating status notice from the page; to avoid being alerted by small changes, set an alert condition by clicking below. Other study details remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-17T14:59:04.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    No significant content changes detected; observed differences appear to be minor visual adjustments and updated timestamps. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T01:29:38.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    2%
    Check dated 2025-10-05T10:26:39.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    The page has been updated to version 3.1.0 and several related topics (MedlinePlus topics on drug safety and quality) have been removed. Overall, core content and time-sensitive information remain largely unchanged.
    Difference
    0.2%
    Check dated 2025-09-28T03:20:11.000Z thumbnail image

Stay in the know with updates to Tezepelumab in Chronic Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tezepelumab in Chronic Urticaria Clinical Trial page.